Welcome to

Q

uality

.

Perf

orm

an

ce.

Imp

rovem

en

t

COMMITTED FOR GLOBAL HEALTH

Q

uality

.

Perf

orm

an

ce.

Imp

rovem

en

t

COMMITTED FOR GLOBAL HEALTH

OUR VISIONOUR VISIONTo become a global

player in pharmaceutical

business with strong presence in all major markets worldwide

by 2015.

Q

uality

.

Perf

orm

an

ce.

Imp

rovem

en

t

COMMITTED FOR GLOBAL HEALTH

SUCCESS STORY AND SUCCESS STORY AND MILESTONESMILESTONES

Mr. Madan Sakhala, CMD,Maxheal Group of Companies ,begun his journey of success with a retail pharmacy venture in early 80’s.Subsequetly

he took a big leap by setting up a midsize pharmaceutical formulation manufacturing unit. He

quickly sensed opportunity of exports to Africa. African markets accepted Maxheal products due to

its high quality, competitive price and timely deliveries. hereafter Maxheal started growing at

rapid pace .credit for this success and growth goes to Mr. Madan Sakhala’s pharmaceutical knowledge, leadership, team building qualities . Maxheal group

is presently engaged in export to more that 15 countries in Africa ,Asia and Latin America.

Q

uality

.

Perf

orm

an

ce.

Imp

rovem

en

t

COMMITTED FOR GLOBAL HEALTH

ACQUISITIONS AND ACQUISITIONS AND ORGANIC GROWTHORGANIC GROWTH

In the year 2008,a wise acquisition move by Maxheal Pharmaceuticals to acquire controlling stakes in M/S Ally Pharma Options Pvt. Ltd has added almost 2 million USD to sales turnover of the Maxheal group of companies. After taking over Ally Pharma its sales is expected to touch 4 million USD in the year 2009-10.this acquisition has also made available to Maxheal much needed additional manufacturing capacity to cater to ever growing west and East Africa market and enabled us to plan growth in newer territories .

Q

uality

.

Perf

orm

an

ce.

Imp

rovem

en

t

COMMITTED FOR GLOBAL HEALTH

ALLY PHARMA OPTION’S manufacturing facility is already approved by many African regulatory authorities such as Kenya, Uganda, Ghana, Nigeria. more

regulatory approvals from countries such as Malawi, Ethiopia, Sudan, Yemen are planned in near future.

Q

uality

.

Perf

orm

an

ce.

Imp

rovem

en

t

COMMITTED FOR GLOBAL HEALTH

ACQUISITIONS AND ACQUISITIONS AND ORGANIC GROWTHORGANIC GROWTH

The ALLY PHARMA has facility to manufacture dosage forms such as ointments, liquid orals, dusting powders in addition to tablets and capsules. Now we are able to supply almost all routine dosage forms that are required by pharmaceuticals distributors worldwide.

Q

uality

.

Perf

orm

an

ce.

Imp

rovem

en

t

COMMITTED FOR GLOBAL HEALTH

NEW CORPORATE OFFICENEW CORPORATE OFFICE

To cope with expanding business, an ultra modern office with best connectivity and I.T. Infrastructure is being built and will be inaugural in year 2010.This will be four storied building with capacity to accommodate over 200 employees

Q

uality

.

Perf

orm

an

ce.

Imp

rovem

en

t

COMMITTED FOR GLOBAL HEALTH

FINANCIAL STRENGTH AND FINANCIAL STRENGTH AND STRATEGY FOR EXPANSION AND STRATEGY FOR EXPANSION AND

DIVERSIFICATIONDIVERSIFICATIONLand, Machinery, Intellectual Assets, Market Capitalization, Office Space, all put together, Maxheal Group’s current Net Worth is over 50 Million USD.

Maxheal is planning a “Initial Public Offering ” of sizeable amount in Indian Stock Market by third quarter of 2010 to raise funds for further expansion and diversification of Surat plant.

Maxheal is accredited “SE 2A” rating in S.M.E. sector by NSIC-CRISIL.

Q

uality

.

Perf

orm

an

ce.

Imp

rovem

en

t

COMMITTED FOR GLOBAL HEALTH

DIVERSIFICATION PLANS AND DIVERSIFICATION PLANS AND BUSINESS DEVELOPMENT STRATEGYBUSINESS DEVELOPMENT STRATEGY

With number of local manufacturers growing in many countries, Maxheal plans to set up independent facility and cater to these manufactures by supplying them semi-finished products such as D. C. granules, drug loaded pallets, taste masked granules etc. Maxheal has in-house printing and packing unit, we plan to supply packing material to overseas manufacturers.

We plan to acquire more marketing authorizations from European companies to strengthen our niche product segment which currently contains C.N.S. category.

• In line with our aspiration to be in niche product market segment in Europe we have acquired products from Rodleben (Germany). These products have valid German Marketing Authorizations and are Planned to be manufactured in our Surat manufacturing facility.

• Following products will be registered and marketed in other EU countries by approaching various European partners either by forming joint venture companies or out-licensed to them with a pre-condition of up-front fee and long term supply agreement.

Product name api application form ENR

Doxepin-RPh 100mg Doxepin film coated tablets 2149104

Doxepin-RPh 50 mg Doxepin film coated tablets 2149103

Fluoxetin-RPh 20mg Fluoxetin hard gelatine capsules 2139488

Levodopa-Carbidopa-RPh 100/25mg

Levodopa tablets 2145925

Levodopa-Carbidopa-RPh 200/50mg

Levodopa tablets 2148797

Melperon-RPh 100mg Melperon tablets 2139518

Melperon-RPh 25mg Melperon tablets 2139517

Melperon-RPh Saft Melperon juice 2139519

Sulpirid-RPh 200mg Sulpirid tablets 2138340

Sulpirid-RPH 50mg Sulpirid hard gelatine capsules 2138310

Valproat-RPh 150mg Valproatgastric juice stable film coated tablets

2148779

Valproat-RPh 300mg Valproatgastric juice stable film coated tablets

2148780

Valproat-RPh 600mg Valproatgastric juice stable film coated tablets

2148781

Valproat-RPh Loesung Valproat solution 2148782

COMMITTED FOR GLOBAL HEALTH

Q

uality

.

Perf

orm

an

ce.

Imp

rovem

en

tEUROPEAN PRODUCT DOSSIERS AND MAsEUROPEAN PRODUCT DOSSIERS AND MAs

For Maxheal Pharma’s Nashik Plant: Item Annual Capacity Tablets 54,00,00,000 Nos. Capsules 84,00,00,000 Nos. Syrup (Dry) 180000 Ltrs. For Maxheal Pharma’s Surat Plant: Item Annual Capacity Tablets 1,000,000,000 Nos. Capsules 60,00,000 Nos.

COMMITTED FOR GLOBAL HEALTH

Q

uality

.

Perf

orm

an

ce.

Imp

rovem

en

t

Qu

ality

.

Perf

orm

an

ce.

Imp

rovem

en

tMANUFACTURING CAPABILITIESMANUFACTURING CAPABILITIES

Q

uality

.

Perf

orm

an

ce.

Imp

rovem

en

t

COMMITTED FOR GLOBAL HEALTH

FOR ALLY PHARMA BOISAR FOR ALLY PHARMA BOISAR PLANTPLANT

Q

uality

.

Perf

orm

an

ce.

Imp

rovem

en

t

COMMITTED FOR GLOBAL HEALTH

Maxheal Pharma’s Q.C. and R&D is equipped with latest instruments and manned by highly experienced and intelligent

professionals

QC & R&DQC & R&D

COMMITTED FOR GLOBAL HEALTH

Q

uality

.

Perf

orm

an

ce.

Imp

rovem

en

t

Qu

ality

.

Perf

orm

an

ce.

Imp

rovem

en

t• Team of techno-marketing professionals well versed with country-

specific regulatory information.• Participation in Trade Exhibitions.• Product packs and designs with international look and appeal.• Excellent support to the Distributors through training, provision of

Promotional Products, gifts.

MARKETING STRENGTHMARKETING STRENGTH

Q

uality

.

Perf

orm

an

ce.

Imp

rovem

en

t

COMMITTED FOR GLOBAL HEALTH

We are committed to social and medical well being of people worldwide. We achieved this by offering best quality and competitively priced pharmaceutical & allied products to

patients through our vast network of distributors and contract manufacturing

partners.

Maxheal supports various social and community based development programs.

OUR COMMITMNET TOWARDS OUR COMMITMNET TOWARDS SOCIETY & HEALTH OF PEOPLESOCIETY & HEALTH OF PEOPLE

Q

uality

.

Perf

orm

an

ce.

Imp

rovem

en

t

COMMITTED FOR GLOBAL HEALTH

All our manufacturing processes and distribution practices are designed and

executed in such a way as to avoid damage to the

environment

OUR CONCERN FOR ENVIRONMENTOUR CONCERN FOR ENVIRONMENT

Q

uality

.

Perf

orm

an

ce.

Imp

rovem

en

t

COMMITTED FOR GLOBAL HEALTH

WHO GMP Certified Company ISO-2008-9000 Certified

‘Niryat Shree’ Award For Excellent Export Sales

Possessing " Two Star Export House" Status

RECOGNITIONSRECOGNITIONS

Q

uality

.

Perf

orm

an

ce.

Imp

rovem

en

t

COMMITTED FOR GLOBAL HEALTH

Supply of pharmaceuticals to distributors across the globe.

Contract manufacturing (only for reputed overseas pharmaceutical companies)

Participation in tenders of various governmental and non-governmental agencies.

We handle turn-key pharmaceutical manufacturing projects and technology transfer.

We act as sourcing partners for our overseas clients for all their pharmaceutical and medico-surgical procurements.

We can offer formulation development services to companies worldwide.

OUR BUSINESS SEGMENTSOUR BUSINESS SEGMENTS

Q

uality

.

Perf

orm

an

ce.

Imp

rovem

en

t

COMMITTED FOR GLOBAL HEALTH

Dynamic and ambitious leadership with excellent business acumen.

Driven by commitment to exceed customer’s expectations

Own pharmaceutical manufacturing facilities at three locations In India.

Over 500 well qualified and experienced workforce.

Alert and dedicated Quality Assurance team

Knowledgeable and hardworking R & D and Regulatory Affairs persons.

Modern machineries capable of handling huge order volumes.

Manufacturing facilities well connected rail and road.

Prompt and sharp finance &logistics department.

OUR STRENGTHSOUR STRENGTHS

Q

uality

.

Perf

orm

an

ce.

Imp

rovem

en

t

COMMITTED FOR GLOBAL HEALTH

Finished Pharmaceutical Formulations

Nutraceuticals

APIs

Semi - Finished Formulations

Drug Loaded Pallets & Ready To Compress Tablet Premix

Pharmaceutical Machinery

Contract Formulation Development

Pharmaceutical Manufacturing Turn-key Projects

OUR PRODUCTS AND OUR PRODUCTS AND SERVICESSERVICES

Q

uality

.

Perf

orm

an

ce.

Imp

rovem

en

t

COMMITTED FOR GLOBAL HEALTH

MAXHEAL PHARMACEUTICALS

Board of Directors

SR. NO.

NAME DESIGNATION OCCUPATION

1Mr. Madan M. Sakhala

ManagingDirector

Business

2Mrs. Hemlata M. Sakhala

Director Business

3 Mr. Mehul M. SakhalaDirector

Business

Above persons are also directors of Ally Pharma Options Pvt Ltd, A Subsidiary of Maxheal group Of companies.

Q

uality

.

Perf

orm

an

ce.

Imp

rovem

en

t

COMMITTED FOR GLOBAL HEALTH

Experienced Management with Proven Track Record

Name Designation Qualifications

Experience (In Years)

Mr. P.V.Mannur.

General Manager- operation

B. Pharm. 34 years

Mr. Nandkishore Deshpande

Manager – (QA/QC)

M.Sc. (Analytical Chemistry)

30 years

Mr. Anil Choudhary.

Manager- Production

M. Pharm. 15 years

Mr. Sanjay Gawali

 

Sr. Manager –International

Marketing

M. Pharm. 22years

Q

uality

.

Perf

orm

an

ce.

Imp

rovem

en

t

COMMITTED FOR GLOBAL HEALTH

Experienced Management with Proven Track Record

Name Designation Qualifications

Experience (In Years)

Mr. Sushil Purohit.

General Manager – Accounts &

Finance

FCA/ C.S. Inter

11 years

Mr. Kailas Somani.

Manager- Purchase

B.Sc 32 years

Mr. Rajnish Singh.

Manager – IT CIC, PTM NIIT 10 years

Mr.Amit Shandilya

Manager-Q.C.  

Mr.Praful Vyas Mr.Uday Savant

Q

uality

.

Perf

orm

an

ce.

Imp

rovem

en

t

COMMITTED FOR GLOBAL HEALTH

Key Performance IndicatorSALES FIGURES

PAST PRESENT AND FUTURE

44595344

7300

8500

10000

0

10002000

30004000

50006000

70008000

900010000

2007 ( 2008 2009 2010 2011

Rs. In Lacs

YEARSCAGR FOR THE PERIOD 2007-2009 IS 16 %

Q

uality

.

Perf

orm

an

ce.

Imp

rovem

en

t

COMMITTED FOR GLOBAL HEALTH

Key Performance Indicator Profitability

Rs.in lacs

198

470

384

758

0

100

200

300

400

500

600

700

800

2006 2007 2008 2009

YEARS

Q

uality

.

Perf

orm

an

ce.

Imp

rovem

en

t

COMMITTED FOR GLOBAL HEALTH

Immediate Release And Sustained Tablet And Capsule Formulations.

Ointments

Syrups and Suspensions

Beta-lactam tablets &capsules,

Liquid and dry powder injections

Small Volume Parenterals and Large Volume Parenterals

DOSAGEDOSAGE FORMS AVAILABLE/PROPOSEDFORMS AVAILABLE/PROPOSED

Q

uality

.

Perf

orm

an

ce.

Imp

rovem

en

t

COMMITTED FOR GLOBAL HEALTH

THERAPEUTIC SEGMENT WE MANAGETHERAPEUTIC SEGMENT WE MANAGE

C.N.S.

C.V.S

G.I.DISEASES

ANTIBIOTICS AND ANTI-INFECTIVES

ARVs

ANTI-TUBERCULAR

ANTI-MALERIAL

VITAMINS AND MINERALS

ANALGESICS AND ANTI-INFLAMMATORY

HORMONES(PROPOSED)

Q

uality

.

Perf

orm

an

ce.

Imp

rovem

en

t

COMMITTED FOR GLOBAL HEALTH

REGULATORY APPROVALS (SEMI-REGUALTED MARKETS)- UNITWISEREGULATORY APPROVALS (SEMI-REGUALTED MARKETS)- UNITWISE

REGULATORY AUTHRORITIES

UNIT-I-NASIK UNIT-II- SACHIN UNIT-III-TARAPUR

NAFDAC-NIGERIA YES PROPOSED YES

NDA UGANDA PROPOSED PROPOSED YES

MEDICINE AND POISON BOARD-KENYA

PROPOSED PROPOSED YES

FDB-GHANA PROPOSED PROPOSED YES

YEMEN-MOH PROPOSED PROPOSED PROPOSED

SUDAN-MOH PROPOSED PROPOSED PROPOSED

POISON BOARD-MALAWI PROPOSED PROPOSED PROPOSED

REGULATORY APPROVALS (SEMI-REGUALTED MARKETS)- UNIT-II-SACHINREGULATORY APPROVALS (SEMI-REGUALTED MARKETS)- UNIT-II-SACHIN

MHRA-UK PROPOSED MOH-GCC PROPOSED

TGA-AUSTRALIA PROPOSED ANVISA-BRAZIL PROPOSED

MCC-SOUTH AFRICA PROPOSED EU-GMP PROPOSED

Q

uality

.

Perf

orm

an

ce.

Imp

rovem

en

t

COMMITTED FOR GLOBAL HEALTH

Our product quality and excellent customer service has helped us grow successfully in all the geographies.

We have sizable market share in countries like Nigeria, Ghana, Kenya, Uganda. Ivory Coast, Costa Rica, Cambodia, Vietnam And

Philippines

We are growing at rapid pace in other markets such as Iraq, Afghanistan and many CIS and Latin American countries.

With acquisition of German dossiers we plan to enter European markets. We would be able to trigger MHRA and EU-GMP

inspections of our Surat Plant by manufacturing these German dossier products in our Surat Plant.

Q

uality

.

Perf

orm

an

ce.

Imp

rovem

en

t

COMMITTED FOR GLOBAL HEALTH

Backed By Over 25 Years Of international experience In Pharmaceutical Manufacturing And Marketing Of Our Visionary Leader Mr.Madan Sakhala, We are poised to enter into an exponential growth phase and thus are looking for likeminded pharmaceutical enterprises across the globe who want to grow with us

WE INVITE BUSINESS PROPOSALS WE INVITE BUSINESS PROPOSALS FORFOR

Distributorship.

Manufacturing joint venture.

Contract manufacturing.

Co-marketing for brand building.

Setting up of overseas office for trade and marketing.

Q

uality

.

Perf

orm

an

ce.

Imp

rovem

en

t

COMMITTED FOR GLOBAL HEALTH

Q

uality

.

Perf

orm

an

ce.

Imp

rovem

en

t

COMMITTED FOR GLOBAL HEALTH

THANKING YOU THANKING YOU

AND AND

LOOKING FORWARD LOOKING FORWARD TO BUILD A LONG LASTING TO BUILD A LONG LASTING

BUSINESS RELATIONSHIP !BUSINESS RELATIONSHIP !

WARM REGARDS,WARM REGARDS,

MAXHEAL FAMILYMAXHEAL FAMILY